Health Care • Medical/Nursing Services
$86.57 ▲ +1.25
(+1.47%)
MKT CAP: $1.29B • VOL: 105.2K
52W L $58 52W H $91
USPH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $781.0M | $671.3M | $604.8M |
| YoY Revenue Growth % | +16.3% | +11.0% | — |
| Gross Profit | $149.7M | $123.9M | — |
| Gross Margin % | 19.2% | 18.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $86.7M | $63.0M | $50.5M |
| Operating Margin % | 11.1% | 9.4% | 8.4% |
| Net Income (GAAP) | $39.6M | $31.4M | $28.2M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $75.1M | $74.9M | $82.0M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $75.1M | $74.9M | $82.0M |
| FCF Margin % | 9.6% | 11.2% | 13.6% |
| Return on Invested Capital (ROIC %) | 11.5% | 8.4% | — |
| Cash & Short-Term Equivalents | $35.6M | $41.4M | — |
| Total Debt (Short + Long Term) | $152.6M | $142.5M | — |
| Total Stockholders' Equity | $476.4M | $488.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR USPH.